WallStSmart

Retractable Technologies Inc (RVP) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Retractable Technologies Inc stock (RVP) is currently trading at $0.72. Retractable Technologies Inc PS ratio (Price-to-Sales) is 0.57. WallStSmart rates RVP as Sell.

  • RVP PE ratio analysis and historical PE chart
  • RVP PS ratio (Price-to-Sales) history and trend
  • RVP intrinsic value — DCF, Graham Number, EPV models
  • RVP stock price prediction 2025 2026 2027 2028 2029 2030
  • RVP fair value vs current price
  • RVP insider transactions and insider buying
  • Is RVP undervalued or overvalued?
  • Retractable Technologies Inc financial analysis — revenue, earnings, cash flow
  • RVP Piotroski F-Score and Altman Z-Score
  • RVP analyst price target and Smart Rating
RVP

Retractable Technologies Inc

NYSE MKTHEALTHCARE
$0.72
$0.00 (-0.04%)
52W$0.62
$1.14

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Retractable Technologies Inc (RVP) · 9 metrics scored

Smart Score

39
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, revenue growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.

Retractable Technologies Inc (RVP) Key Strengths (3)

Avg Score: 10.0/10
Price/SalesValuation
0.5710/10

Paying less than $1 for every $1 of annual revenue

Price/BookValuation
0.2810/10

Trading below book value, meaning the market prices it less than net assets

Revenue GrowthGrowth
73.20%10/10

Revenue surging 73.20% year-over-year

Supporting Valuation Data

Price/Sales (TTM)
0.569
Undervalued
EV/Revenue
0.141
Undervalued

Retractable Technologies Inc (RVP) Areas to Watch (6)

Avg Score: 0.8/10
Return on EquityProfitability
-10.80%0/10

Company is destroying shareholder value

Operating MarginProfitability
-49.10%0/10

Losing money on operations

EPS GrowthGrowth
-66.70%0/10

Earnings declining -66.70%, profits shrinking

Profit MarginProfitability
-22.90%0/10

Company is losing money with a negative profit margin

Institutional Own.Quality
7.00%2/10

Very low institutional interest at 7.00%

Market CapQuality
$24M3/10

Micro-cap company with very limited liquidity and high volatility

Retractable Technologies Inc (RVP) Detailed Analysis Report

Overall Assessment

This company scores 39/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book, Revenue Growth. Valuation metrics including Price/Sales (0.57), Price/Book (0.28) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 73.20%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, EPS Growth. Growth concerns include EPS Growth at -66.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -10.80%, Operating Margin at -49.10%, Profit Margin at -22.90%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -10.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 73.20% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

RVP Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

RVP's Price-to-Sales ratio of 0.57x sits near its historical average of 0.55x (71th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 0.57x set in Mar 2026, and 7% above its historical low of 0.53x in Mar 2026.

Compare RVP with Competitors

Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Retractable Technologies Inc (RVP) · HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

The Big Picture

Retractable Technologies Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 38M with 73% growth year-over-year. The company is currently unprofitable, posting a -22.9% profit margin.

Key Findings

Strong Revenue Growth

Revenue growing at 73% YoY, reaching 38M. This pace significantly outperforms most MEDICAL INSTRUMENTS & SUPPLIES peers.

Operating at a Loss

The company is unprofitable with a -22.9% profit margin. The path to breakeven will be the key catalyst.

Negative Free Cash Flow

Free cash flow is -1M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Growth sustainability: can Retractable Technologies Inc maintain 73%+ revenue growth, or will competition slow it down?

Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Retractable Technologies Inc.

Bottom Line

Retractable Technologies Inc is a high-conviction growth story with revenue accelerating at 73% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -22.9% margins and premium valuation suggest patience until the unit economics mature further.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(0 last 3 months)

Total Buys
0
Total Sells
0

Data sourced from SEC Form 4 filings

Last updated: 8:23:44 AM

About Retractable Technologies Inc(RVP)

Exchange

NYSE MKT

Sector

HEALTHCARE

Industry

MEDICAL INSTRUMENTS & SUPPLIES

Country

USA

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, the rest of North and South America, and internationally. The company is headquartered in Little Elm, Texas.